Ozempic vs Wegovy
Drug comparison
Last updated 2026-05-28 15:46 UTCOzempic and Wegovy both contain the same active ingredient, semaglutide, and are made by Novo Nordisk, but they are FDA-approved for different uses: Ozempic treats type 2 diabetes and reduces cardiovascular risk and chronic kidney disease, while Wegovy is approved for obesity and also reduces cardiovascular risk. Both are given as injections under the skin, but they are not interchangeable—Ozempic is prescribed for diabetes, and Wegovy is prescribed for weight management.
AI summary of the sources below.
| Ozempic | Wegovy | |
|---|---|---|
| Active ingredient | semaglutide | semaglutide |
| Manufacturer | novo-nordisk | novo-nordisk |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes, cardiovascular risk reduction, chronic kidney disease | obesity, cardiovascular risk reduction |
| Label updated | 2026-01-30 | 2026-05-05 |